GX-110

N/A

Report date: 2025/03/18 14:31:28

Base Information

Drug NameGX-110
Drug Alias NameGX-110HB-110GX-110EHB-110E
ClassificationVaccines > Development/production technology > Nucleic acid vaccine > DNA vaccineVaccines > Application > Therapeutic vaccine
Mechanisms of ActionInterleukin-12 receptor modulatorsHBV DNA Polymerase inhibitors
TargetsHBV DNA PolymeraseInterleukin-12 receptor
Therapy Area/IndicationsHepatitis B, ChronicHepatitis B
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritorySouth Korea
CombinationsNo
Global Highest StatusPending (Phase 2 Clinical)
Highest Status in ChinaN/A
Originator CompaniesDong-A Pharmaceutical Co LtdGannex Pharma Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesGannex Pharma Co LtdDong-A Pharmaceutical Co Ltd
Active IndicationsN/A
Inactive IndicationsHepatitis B, ChronicHepatitis B

Other Information

ATC CodeN/A
Related LinksN/A